232 related articles for article (PubMed ID: 33414028)
1. PGx in psychiatry: Patients' knowledge, interest, and uncertainty management preferences in the context of pharmacogenomic testing.
Kastrinos A; Campbell-Salome G; Shelton S; Peterson EB; Bylund CL
Patient Educ Couns; 2021 Apr; 104(4):732-738. PubMed ID: 33414028
[TBL] [Abstract][Full Text] [Related]
2. Providers' perspectives on the clinical utility of pharmacogenomic testing in pediatric patients.
Liko I; Lee YM; Stutzman DL; Blackmer AB; Deininger KM; Reynolds AM; Aquilante CL
Pharmacogenomics; 2021 Apr; 22(5):263-274. PubMed ID: 33657875
[No Abstract] [Full Text] [Related]
3. Barriers to clinical adoption of pharmacogenomic testing in psychiatry: a critical analysis.
Virelli CR; Mohiuddin AG; Kennedy JL
Transl Psychiatry; 2021 Oct; 11(1):509. PubMed ID: 34615849
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenomic testing in oncology: a health system's approach to identify oncology provider perspectives.
Bhatt M; Peshkin BN; Kazi S; Schwartz MD; Ashai N; Swain SM; Smith DM
Pharmacogenomics; 2023 Nov; 24(16):859-870. PubMed ID: 37942634
[No Abstract] [Full Text] [Related]
5. Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testing.
Smith DM; Namvar T; Brown RP; Springfield TB; Peshkin BN; Walsh RJ; Welsh JC; Levin B; Brandt N; Swain SM
Pharmacogenomics; 2020 Oct; 21(15):1085-1094. PubMed ID: 32969759
[No Abstract] [Full Text] [Related]
6. User Experiences of Pharmacogenomic Testing and Opinions among Psychiatry Patients.
Virelli CR; Ebrahimi M; Mohiuddin AG; Tomasi J; Lisoway AJ; Herbert D; Marshe VS; Kidd SA; Ferenbok J; Kennedy JL
J Pers Med; 2023 Dec; 14(1):. PubMed ID: 38248723
[TBL] [Abstract][Full Text] [Related]
7. Patients' Perspectives on Psychiatric Pharmacogenetic Testing.
Liko I; Lai E; Griffin RJ; Aquilante CL; Lee YM
Pharmacopsychiatry; 2020 Nov; 53(6):256-261. PubMed ID: 32583391
[TBL] [Abstract][Full Text] [Related]
8. Patients' perspectives of a pharmacist-provided clinical pharmacogenomics service.
Martin JL; Lee YM; Corbin LW; Colson R; Aquilante CL
Pharmacogenomics; 2022 Jun; 23(8):463-474. PubMed ID: 35469451
[No Abstract] [Full Text] [Related]
9. Perspectives on the Clinical Use of Pharmacogenetic Testing in Late-Life Mental Healthcare: A Survey of the American Association of Geriatric Psychiatry Membership.
Bousman CA; Oomen A; Jessel CD; Tampi RR; Forester BP; Eyre HA; Lavretsky H; Müller DJ
Am J Geriatr Psychiatry; 2022 May; 30(5):560-571. PubMed ID: 34740522
[TBL] [Abstract][Full Text] [Related]
10. Medical education in pharmacogenomics-results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx).
Just KS; Steffens M; Swen JJ; Patrinos GP; Guchelaar HJ; Stingl JC
Eur J Clin Pharmacol; 2017 Oct; 73(10):1247-1252. PubMed ID: 28669097
[TBL] [Abstract][Full Text] [Related]
11. Description of Pharmacogenomic Testing Among Patients Admitted to the Intensive Care Unit After Cardiovascular Surgery.
Peterson PE; Nicholson WT; Moyer AM; Arendt CJ; Smischney NJ; Seelhammer TG; Krecke CA; Haney RM; Yaw EJ; Chlan LL
J Intensive Care Med; 2021 Nov; 36(11):1281-1285. PubMed ID: 32734840
[TBL] [Abstract][Full Text] [Related]
12. Assessing the impact of pre-test education on patient knowledge, perceptions, and expectations of pharmacogenomic testing to guide antidepressant use.
Sloat NT; Yashar BM; Ellingrod VL; Ward KM
J Genet Couns; 2022 Dec; 31(6):1373-1382. PubMed ID: 35900228
[TBL] [Abstract][Full Text] [Related]
13. Perception and knowledge of pharmacogenetics among Brazilian psychiatrists.
Almeida BC; Gonçalves ED; de Sousa MH; Osis MJMD; de Brito Mota MJB; Planello AC
Psychiatry Res; 2021 Dec; 306():114238. PubMed ID: 34656849
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization.
Bar-Peled Y; Denton JJ; Richards JL; Brown D; Worthey E; Strong TV
Pharmacogenomics; 2024 Mar; 25(4):207-216. PubMed ID: 38506331
[No Abstract] [Full Text] [Related]
15. Use of a consultation service following pharmacogenetic testing in psychiatry.
Krause DS; Dowd D
Pharmacogenomics; 2022 Apr; 23(5):327-333. PubMed ID: 35296147
[TBL] [Abstract][Full Text] [Related]
16. A Narrative Review on Pharmacogenomics in Psychiatry: Scientific Definitions, Principles, and Practical Resources.
Palumbo S; Mariotti V; Pellegrini S
J Clin Psychopharmacol; 2024 Jan-Feb 01; 44(1):49-56. PubMed ID: 38100778
[TBL] [Abstract][Full Text] [Related]
17. Child and adolescent psychiatrists' use, attitudes, and understanding of genetic testing and pharmacogenetics in clinical practice.
Soda T; Merner AR; Small BJ; Torgerson LN; Muñoz K; Austin J; Storch EA; Pereira S; Lázaro-Muñoz G
Psychiatry Res; 2023 Jul; 325():115246. PubMed ID: 37172398
[TBL] [Abstract][Full Text] [Related]
18. Preferences for pharmacogenomic testing in polypharmacy patients: a discrete choice experiment.
Chen C; Roberts MH; Raisch DW; Thompson TA; Bachyrycz A; Borrego ME
Per Med; 2022 Nov; 19(6):535-548. PubMed ID: 36317592
[TBL] [Abstract][Full Text] [Related]
19. Clinical implementation of preemptive pharmacogenomics in psychiatry.
Skokou M; Karamperis K; Koufaki MI; Tsermpini EE; Pandi MT; Siamoglou S; Ferentinos P; Bartsakoulia M; Katsila T; Mitropoulou C; Patrinos GP;
EBioMedicine; 2024 Mar; 101():105009. PubMed ID: 38364700
[TBL] [Abstract][Full Text] [Related]
20. Prescription patterns of outpatients and the potential of multiplexed pharmacogenomic testing.
Chan SL; Liew HZW; Nguyen F; Thumboo J; Chow WC; Sung C
Br J Clin Pharmacol; 2021 Mar; 87(3):886-894. PubMed ID: 32559336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]